Cannabis Law Report

NOVEMBER 25, 2021

The Food and Drug Administration (FDA) recently approved the use of CBD to help treat the condition in individuals as young as two years old. The use of CBD seems to ease the number of seizures patients have considerably, which has caused many medical professionals to take notice and begin prescribing it to others.

CBD 52

CBD Clinical Trials Epilepsy Chronic Pain 52

Greencamp

FEBRUARY 2, 2019

Even though cannabis and cannabinoid-derived pharmaceuticals are both frequently used by HIV/AIDS patients, several studies show that something interesting happens when cannabis is consumed. Examples include pneumonia, cancers, tuberculosis, chronic diarrhea, and inflammation-based conditions such as meningitis and encephalitis.

Marijuana 110

Marijuana Therapy Cannabinoids Patients 110

Greencamp

AUGUST 16, 2018

Because of the very rapid progression of ALS in the majority of patients, understanding how cannabis could help in the alleviation of symptoms is incredibly important for ALS sufferers. Both upper and lower motor neurons suffer severe damage in ALS patients. As few as 10% of ALS patients live longer than 10 years after being diagnosed.

Strains 94

Strains Cannabinoids Research and Development Indica 94

Kind Meds (Cannabis Education Blog)

NOVEMBER 16, 2022

CBN has the potential to treat many other conditions. Here are some of the most common effects CBN may have on patients: Wound Healing and Anti-Inflammatory Properties. CBN is believed to relieve symptoms of conditions in which seizures are a symptom, including epilepsy. Dental conditions. Other Potential Uses of CBN.

Sleep 94

Sleep Cannabinoids THC CBD 94

SpeedWeed

AUGUST 4, 2021

For the first time, he was a patient and not a criminal. They presented case studies about patients who have had incredible success from their cannabis treatments. I really couldn’t believe what I was hearing, but this was definitely the tipping point for me. I attended my first medical cannabis symposium in Sydney in 2016.

Chronic Pain 52

Chronic Pain Research and Development Medicine Supply Chain 52

MMJ Recs

JULY 11, 2020

A lot more research needs to be done on this therapy, including peer reviews and larger clinical trials, in order to get a full picture. Additionally, the forms they studied were high in anti-inflammatory CBD but low in THC (which is what provides the patient with the cannabis high). What about medical marijuana and coronavirus?

Research and Development 52

Research and Development Treatment Clinical Trials Therapy 52

The Cannigma

DECEMBER 12, 2022

And while most psychedelics are currently illegal in the United States and around the world, researchers are exploring their use in medicine to treat conditions such as depression, PTSD, addiction, anxiety, OCD, migraines, end of life acceptance of mortality, and eating disorders. Now, psychedelic research is booming.

History 119

History Microdosing Research and Development Clinical Trials 119

SpeedWeed

MARCH 5, 2021

One, they have been determined by the US Food and Drug Administration to be clinically safe and effective treatments for a specific medical condition. Removing cannabis from the CSA, a/k/a descheduling, would not amend its legal definition in such a way that it would meet either requirement. Authors Tracy Gallegos and Neville M.

Business 52

Business Policy Clinical Trials Research and Development 52

Medical Cannabis Seedbank

FEBRUARY 26, 2018

A regular occurrence amongst cancer patients being treated with chemotherapy is intense bouts of nausea, vomiting, and retching. states where cannabis is legalized chemo-induced nausea or vomiting is now a qualifying condition to receive THC based treatments. When patient. Encourage appetite. Reduction of cancer-related pain.

Treatment 63

Treatment Patients Clinical Trials THC 63

Cannabis Law Report

JANUARY 5, 2022

This patent issuance is rewarding and timely as we launch our Phase 2 trial of MYMD-1 as a therapy for sarcopenia, frailty, and aging, which is currently recruiting patients,” said Chris Chapman, M.D., The patent will be issued on January 11, 2022. President, Director and Chief Medical Officer of MyMD. 2 Goates et al. Robert Schatz.

Pharmaceutical 52

Pharmaceutical Clinical Trials Therapy Treatment 52

CannaMD

AUGUST 8, 2020

Drugs, substances, and certain chemicals used to make drugs are classified into five categories (known as schedules ) depending on the Department of Drug Enforcement Agency (DEA)’s definition of the drug’s acceptable medical use and abuse/dependency potential. ”, our first instinct is to remain patients that CBD is CBD.

CBD 99

CBD DEA Research and Development Hemp 99

The Cannigma

JUNE 15, 2021

Some healthcare professionals are already encouraged by what is known, much of it anecdotal accounts from patients in their practices. The first clinical research done on CBD as a potential treatment for epilepsy was in 1980, but the information gleaned didn’t make its way to the public eye until decades later. Easy access.

CBD 122

CBD Research and Development Epilepsy Extraction 122

Puff Puff Post

NOVEMBER 5, 2019

5, 2019 /CNW/ – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX: IN; OTCQX: IMLFF), today announced the filing of a Clinical Trial Application (“CTA”) in the Netherlands to initiate a Phase 1 human clinical trial for INM-755 in healthy volunteers. VANCOUVER, Nov.

Clinical Trials 40

Clinical Trials Pharmaceutical Cannabinoids Data 40

Cannabis Law Report

JANUARY 20, 2022

ELE-Psilo program expected to enter clinical trials in Q2 2022 and to target the pressing need for rapid-acting antidepressants compatible with existing healthcare infrastructure and insurance. Third-party clinical studies investigating oral psilocybin have reported compelling anti-depressant effects. II is a $287.5

Therapy 52

Therapy Research and Development Business Access 52

CannaMD

MARCH 8, 2020

In January of 2020, the Journal of the American College of Cardiology published a review titled Marijuana Use in Patients With Cardiovascular Disease. Few randomized clinical trials have been conducted or are planned to explore the effects of marijuana on cardiovascular risk. population, has an arrhythmia.

Patients 79

Patients Marijuana Research and Development Clinical Trials 79

Project CBD

MAY 3, 2023

Dr. Goldstein has treated thousands of patients with medical cannabis. She is the medical director of Canna-Centers Wellness & Education and the clinical advisor to Cannformatics. CannMed: For what conditions do you think CBG has the most promise? It can be a very difficult condition. What are you most interested in?

Cannabinoids 209

Cannabinoids Sleep Clinical Trials CBD 209

Cannabis Law Report

APRIL 13, 2022

Complementary businesses combine to create a preeminent North American platform with operations spanning 13 wellness clinics, four research sites and one bioanalytical laboratory. Hosting clinical trials for MDMA ( MAPS Public Benefit Corporation), psilocybin (the Usona Institute), LSD (MindMed) and ketamine (the University of Utah ).

Clinical Trials 52

Clinical Trials Research and Development Therapy Treatment 52

Cannabis Law Report

OCTOBER 26, 2019

One such circumstance is a clinical trial. A clinical trial in Australia must have an Australian sponsor (whether it be an individual (e.g., Two of the avenues for supply of UTGs for clinical trials are the Clinical Trial Exemption (CTX) Scheme and the Clinical Trial Notification (CTN) Scheme.

Clinical Trials 45

Clinical Trials Medicine Research and Development Compliance 45

The Cannigma

MARCH 12, 2021

But sometimes one unintended consequence of adult-use legalization is that the market no longer caters to medical patients. But the doctor isn’t giving the patient any guidance. Listen & Subscribe: Very few medical cannabis advocates are against the full legalization of the plant for all adults. How do you address that?

Legalization 128

Legalization Patients Education Dispensary 128

Canna Law Blog

MARCH 4, 2020

Similar to ketamine, psilocybin has shown great promise in clinical trials for helping to effectively treat depression and PTSD (and we’ve written about psilocybin several times on this blog, including here and here ). Recently, the decriminalization of psilocybin (by various cities) has been in the news as an emerging medicine.

Therapy 90

Therapy Legalization Chronic Pain DEA 90

Project CBD

FEBRUARY 28, 2023

Under section 201(ff)(3)(B) of the Federal Food, Drug, and Cosmetic Act — in what some refer to as the “drug preclusion clause” 4 — any substance that is an active ingredient in an approved drug product, or that is being publicly investigated as such, is excluded from the definition of a legal dietary supplement ingredient. Epilepsy Behav.

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Info

OCTOBER 11, 2019

Now, clinical studies are about to get underway at an Australia university, to track changes in actual dementia patients to see if cannabis can help. Dementia is a catch-all term for the conditions that cause declining memory and thinking skills, including Alzheimer’s, Parkinson’s and vascular dementia.

Treatment 45

Treatment Clinical Trials Cannabinoids Cannabis 45

Puff Puff Post

NOVEMBER 5, 2019

5, 2019 /CNW/ – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX: IN; OTCQX: IMLFF), today announced the filing of a Clinical Trial Application (“CTA”) in the Netherlands to initiate a Phase 1 human clinical trial for INM-755 in healthy volunteers. VANCOUVER, Nov.

Clinical Trials 8

Clinical Trials Pharmaceutical Cannabinoids Data 8

Canna Law Blog

MARCH 4, 2020

Similar to ketamine, psilocybin has shown great promise in clinical trials for helping to effectively treat depression and PTSD (and we’ve written about psilocybin several times on this blog, including here and here ). Recently, the decriminalization of psilocybin (by various cities) has been in the news as an emerging medicine.

Legalization 52

Legalization Therapy Chronic Pain DEA 52

CannaMD

OCTOBER 7, 2019

Besides going against all the classic “munchies/stoner” stereotypes, this finding is especially puzzling as cannabis is often used to increase weight gain in patients with medical conditions such as HIV/AIDS and cancer. So why are medical marijuana patients gaining weight when they need to, but losing weight when they don’t?

Marijuana 105

Marijuana Cannabinoids Patients Conditions 105

The Cannigma

FEBRUARY 11, 2021

There was definitely no way of ensuring that you got the same effect from it consistently. One of the things she does is collect and analyze data about cannabis products and how patients with different medical conditions respond to them. The lack of correlation between the weight of the patient and the dose,” Gordon says.

Wellness and Beauty 125

Wellness and Beauty Data Patients Medicine 125

The Cannigma

APRIL 8, 2021

So yeah, I spend my time helping physicians and nurses more than I do counting bills and talking to patients. The doctor diagnoses the condition and chooses a specific medicine. Perhaps the patient turns out to be allergic to that medicine or whatnot. What I see is more of a bifurcated model where you have true medical patients.

Medicine 108

Medicine Cannabinoids Cannabis THC 108

The Cannigma

MAY 7, 2021

There were somewhat of a, I want to say grey, but it wasn’t the pharma routes for patients in the US who wanted to get certain products, you know? What do those more pharmaceutical standards mean for patients? MSO: Obviously, every country is different but within Europe and certain rainy islands close to it. SM: I think it’s stability.

Supply Chain 120

Supply Chain Patients Access Hemp 120

Cannabis Law Report

DECEMBER 21, 2019

Autism is a very serious health condition that affects patients’ communication and social interaction skills thus making the development and maintenance of a social relationship very difficult. Reports gathered show that the behavioral patterns patients show are more repetitive than erratic.

Research and Development 59

Research and Development CBD Conditions Therapy 59

Cannabis Law Report

NOVEMBER 24, 2021

Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access.

Research and Development 52

Research and Development Medicine Access Media 52

The Cannigma

DECEMBER 22, 2021

EG: Yeah, definitely. It doesn’t mean, necessarily, that the market should go to full legalization within a year or two, because it won’t happen so fast, but you can have more patients with other medical indications that were not given cannabis before. At the moment, you said that they could potentially add more conditions.

Research and Development 79

Research and Development Oil Cannabis Clinical Trials 79

Cannabis Law Report

OCTOBER 29, 2019

Wakshlag is well-known in the veterinary medicine community as the first doctor to conduct an efficacy study in dogs in a clinical trial at Cornell using ElleVet CBD/CBDA on dogs with multi-joint discomfort. The clinical trial results confirmed more than 80% of dogs showed significant or dramatic improvement.

Safety 45

Safety CBD Clinical Trials Oil 45

Cannabis Law Report

OCTOBER 17, 2019

Plants with a level of THC content low enough that they are considered non-intoxicating—with the specific definitions varying depending on the jurisdiction—are classified as industrial hemp. Each has different levels of a compound called tetrahydrocannibinol (THC), which is what gives marijuana users their high.

Law 40

Law Seed-To-Sale Hemp Recreational 40

Cannabis Law Report

JUNE 30, 2019

Lou Correa (D-CA) that would require the VA to conduct clinical trials on the therapeutic potential of cannabis in the treatment of such service-related conditions as post-traumatic stress disorder and chronic pain. The panel also took up a bill sponsored by Rep.

Chronic Pain 40

Chronic Pain Legislation Treatment Programs 40